Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer

by Shingo Tsuji, Xuguang Chen, Bryan Hancock, Veronica Hernandez, Barbara Visentin, Katherine Reil, Roger Sabbadini, Matthew Giacalone, WT Godbey
Published 2016-01-01